Isolation and characterization of tissue-type plasminogen activator-binding proteoglycans from human umbilical vein endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 665-672

  Böhm, Thomas ^a   Geiger, Margarethe ^a   Binder, Bernd R ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Department for Vascular Biology ^*  (Austria)

Author keywords

endothelial cells; glycosaminoglycans; proteoglycans; tissue type plasminogen activator

Indexed keywords

CELL EXTRACT; PROTEOGLYCAN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CELL LABELING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; UMBILICAL VEIN;

EID: 0029968841     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.665     Document Type: Article

References (49)

1. Bachmann F. Molecular aspects of plasminogen, plasminogen activators and plasmin. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and Thrombosis, Volume 1. Edinburgh, Scotland: Churchill Livingstone; 1994:575-613.
2. Collen D, Lijnen HR. Fibrin-specific fibrinolysis. In: Brakman P, Kluft C, eds. Plasminogen Activation in Fibrinolysis, in Tissue Remodeling, and in Development: Annals of the New York Academy of Sciences, Volume 667. New York, NY: New York Academy of Sciences; 1992:259-271.
3. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. In: Brakman P, Kluft C, eds. Plasminogen Activation in Fibrinolysis, in Tissue Remodeling, and in Development: Annals of the New York Academy of Sciences, Volume 667. New York, NY: New York Academy of Sciences; 1992:1-12.
4. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. In: Brakman P, Kluft C, eds. Plasminogen Activation in Fibrinolysis, in Tissue Remodeling, and in Development: Annals of the New York Academy of Sciences, Volume 667. New York, NY: New York Academy of Sciences; 1992:249-258.
5. Stadler M, Hauert J, Kruithof EK, Bachmann F. Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA. Br J Haematol. 1985;61:169-176.
6. Agnelli G, Levi M, Cosmi B, ten Cate JW, Nenci GG. Additive effect of dDAVP and standard heparin in increasing plasma t-PA. Thromh Haemost. 1989;61:507-510.
7. Nilson IM, Holmberg L, Aberg M, Vilhardt H. The release of plasminogen activator and factor VIII after injection of dDAVP in healthy volunteers and in patients with von Willebrand's disease. Scand J Haematol. 1980;24:351-359.
8. Levin EG, Marzec U, Anderson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest. 1984;74:1988-1995.
9. Hans M, Collen D. Secretion of tissue type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J. Lab Clin Med. 1987;109:97-104.
10. Agnelli G, Borm J, Cosmi B, Levi M, ten Cate JW. Effect of standard heparin and low molecular weight heparin (Kabi 2165) on fibrinolysis. Thromb Haemost. 1988;60:311-313.
11. Huber K, Resch I, Rose D, Probst P, Kaindl F, Binder BR. Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment. Thromb Res. 1989;55:779-784.
12. Beebe DP. Binding of tissue plasminogen activator to human umbilical vein endothelial cells. Thromb Res. 1987;46:241-254.
13. Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to human endothelial cells. J Clin Invest. 1987;80:1712-1719.
14. Barnathan ES, Kuo A, Van der Keyl H, McCrae R, Larsen GR, Cines DB. Tissue-type plasminogen activator binding to human endothelial cells: evidence for two distinct binding sites. J Biol Chem. 1988;263:7792-7799.
15. Russell ME, Quertermous T, Declerk PJ, Collen D, Haber E, Homey CJ. Binding of tissue-type plasminogen activator with human endothelial cell monolayers: characterization of the high affinity interaction with plasminogen activator inhibitor-1. J Biol Chem. 1990;265:2569-2575.
16. Ramakrishnan V, Sincropi DV, Dere R, Darbonne WC, Bechtol KB, Baker JB. Interaction of wild-type and catalytically inactive mutant forms of tissue plasminogen activator with human umbilical vein endothelial cell monolayers. J Biol Chem. 1990;265:2755-2762.
17. Hajjar KA, Hamel NM. Identification and characterization of the human endothelial cell binding sites for tissue plasminogen activator and urokinase. J Biol Chem. 1990;265:2908-2916.
18. Hajjar KA. The endothelial cell tissue plasminogen activator receptor: specific interaction with plasminogen. J Biol Chem. 1991; 266:21962-21970.
19. Felez J, Chanquia CA, Levin EG, Miles LA, Plow EF. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood. 1991;78:2318-2327.
20. Sakata Y, Okada M, Noro A, Matsuda M. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells. J Biol Chem. 1988;263:1960-1969.
21. Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-plasminogen activator. J Cell Biol. 1990;110:155-163.
22. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator, I: identity with annexin II. J Biol Chem. 1994;269:21191-21197.
23. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA), II: annexin II mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem. 1994;269:21198-21203.
24. Binder BR, Spragg J, Austen KF. Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. J Biol Chem. 1979;254:1998-2003.
25. Ecke S, Geiger M, Binder BR. Glycosaminoglycans specifically stimulate the inhibition of 55kD but not of 33kD urokinase by protein C inhibitor. Ann Hematol. 1992;64(suppl):A64. Abstract.
26. Pâques EP, Stöhr HA, Heimburger N. Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin. Thromb Res. 1986;42:797-807.
27. Dosne AM, Bendetowicz AV, Kher A, Samama M. Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and a low molecular weight heparin. Thromb Res. 1988;52:627-630.
28. Stein PL, van Zonneveld A-J, Pannekoek H, Strickland S. Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin. J Biol Chem. 1989;264:15441-15444.
29. Edelberg JM, Pizzo SV. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. Biochemistry. 1990;29:5906-5911.
30. Andrade-Gordon P, Strickland S. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. Biochemistry. 1986;25:4033-4040.
31. Oohira A, Wight TN, Bornstein P. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem. 1983; 258:2014-2021.
32. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Anna Rev Biochem. 1991;60:443-475.
33. Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem. 1986;261:7507-7517.
34. Nader HB, Dietrich CP, Buonassisi V, Colburn P. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. Proc Natl Acad Sci USA. 1987;84:3565-3569.
35. Olivecrona T, Bengtsson G, Marklund SE, Lindahl U, Höök M. Heparin-lipoprotein lipase interactions. Fed Proc. 1977;36:60-69.
36. Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost. 1991;66: 6-15.
37. Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis. 1992;3: 439-449.
38. Rosenfeld L, Kuo A, Hirsh J, Klugherz B, Gardell SJ, Cines DB, Barnathan ES. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells. Blood. 1992; 80:1486-1495.
39. Andrade-Gordon P, Strickland S. Fractionation of heparin by chromatography on a tissue plasminogen activator-sepharose column. Proc Natl Acad Sci USA. 1990;87:1865-1869.
40. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52: 2745-2756.
41. Gospodarowicz J. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem. 1975;250:2515-2520.
42. Shively JE, Conrad HE. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 1976;15: 3932-3942.
43. Weber K, Osborn M. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969;244:4406-4412.
44. Davies G, Stark G. Use of suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. Proc Natl Acad Sci USA. 1970;66:651-659.
45. Morrissey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981;117:307-310.
46. Cowman MK, Slahetka ME, Hittner DM, Kim J, Forino M, Gadelrab G. Polyacrylamide-gel electrophoresis and alcian blue staining of sulfated glycosaminoglycan oligosaccharides. Biochem J. 1984;221:707-716.
47. Lowe-Krentz LJ, Joyce JG. Venous and aortic porcine endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge. Anal Biochem. 1991;193: 155-163.
48. Speiser W, Anders E, Binder BR, Müller-Berghaus G. Clot lysis mediated by cultured human microvascular endothelial cells. Thromb Haemost. 1988;60:463-467.
49. Silvestro L, Ruikun C, Sommer F, Minh Duc T, Biancone L, Montrucchio G, Camussi G. Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalix, evaluated by electron spectroscopy chemical analysis. Semin Thromb Hemost. 1994;20:214-222.